BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10661768)

  • 21. Re: Stålhammar G: Delays between uveal melanoma diagnosis and treatment increase the risk of metastatic death (Ophthalmology. 2023 Nov 21:S0161-6420(23)00856-4. doi: 10.1016/j.ophtha.2023.11.021. Online ahead of print).
    Hussain RN; Coupland SE; Heimann H; Eleuteri A
    Ophthalmology; 2024 Jun; ():. PubMed ID: 38878047
    [No Abstract]   [Full Text] [Related]  

  • 22. Do Short Delays in Treatment Affect Uveal Melanoma Prognosis?
    Harbour JW; Correa ZM; Stacey AW
    Ophthalmology; 2024 Jun; ():. PubMed ID: 38878046
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum : Uveal Melanoma Treatment and Prognostication.
    Dogrusöz M; Jager MJ; Damato B
    Asia Pac J Ophthalmol (Phila); 2017; 6(3):305. PubMed ID: 28561548
    [No Abstract]   [Full Text] [Related]  

  • 24. Case report: Immunotherapy inducing unexpected overall survival in choroidal melanoma: about a case.
    Elhaitmy Y; El Anssari S; Fournel P; Mellas N; Bouleftour W; Lamuraglia M
    Front Oncol; 2024; 14():1319792. PubMed ID: 38706606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Metastases from Choroidal Melanoma.
    Madani A; Omar NE; Mustafa G; Petkar M; Mohamed S; Al Kuwari M; Karim SA; Mohsen R
    Clin Case Rep; 2022 Jul; 10(7):e6080. PubMed ID: 35865765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT variants and pitfalls in malignant melanoma.
    Aide N; Iravani A; Prigent K; Kottler D; Alipour R; Hicks RJ
    Cancer Imaging; 2022 Jan; 22(1):3. PubMed ID: 34983677
    [No Abstract]   [Full Text] [Related]  

  • 27. AMBRA1 attenuates the proliferation of uveal melanoma cells.
    Zhao B; Yang Y; Cun B; Chen P
    Open Med (Wars); 2022; 17(1):1-14. PubMed ID: 34901460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Natural Killer Cells in Uveal Melanoma.
    Javed A; Milhem M
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33317028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
    Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
    Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
    BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report.
    Yunoki T; Tabuchi Y; Kondo T; Ishii Y; Hayashi A
    Oncol Lett; 2017 Jun; 13(6):4169-4172. PubMed ID: 28599417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an Immunogenic Subset of Metastatic Uveal Melanoma.
    Rothermel LD; Sabesan AC; Stephens DJ; Chandran SS; Paria BC; Srivastava AK; Somerville R; Wunderlich JR; Lee CC; Xi L; Pham TH; Raffeld M; Jailwala P; Kasoji M; Kammula US
    Clin Cancer Res; 2016 May; 22(9):2237-49. PubMed ID: 26712692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the metastasis suppressor BRMS1 in uveal melanoma.
    Ventura BV; Quezada C; Maloney SC; Fernandes BF; Antecka E; Martins C; Bakalian S; di Cesare S; Burnier MN
    Ecancermedicalscience; 2014; 8():410. PubMed ID: 24688598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uveal melanoma: Ocular and systemic disease.
    Miyamoto C; Balazsi M; Bakalian S; Fernandes BF; Burnier MN
    Saudi J Ophthalmol; 2012 Apr; 26(2):145-9. PubMed ID: 23960985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular testing prognostic of low risk in epithelioid uveal melanoma in a child.
    Dimaras H; Parulekar MV; Kwok G; Simpson ER; Ali A; Halliday W; Shago M; Harbour JW; Héon E; Gallie BL; Chan HS
    Br J Ophthalmol; 2013 Mar; 97(3):323-6. PubMed ID: 23292925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low back pain as the presenting sign in a patient with primary extradural melanoma of the thoracic spine--a metastatic disease 17 years after complete surgical resection.
    Katalinic D; Anic B; Stern-Padovan R; Mayer M; Sentic M; Cikes N; Zarkovic K; Dotlic S; Plestina S
    World J Surg Oncol; 2011 Nov; 9():150. PubMed ID: 22093436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary spinal cord melanoma.
    Kim MS; Yoon DH; Shin DA
    J Korean Neurosurg Soc; 2010 Aug; 48(2):157-61. PubMed ID: 20856666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short length of stay and rapid recovery to normal function after surgery for metastatic melanoma to abdominal and retroperitoneal viscera.
    Dengel LT; Slingluff CL
    J Surg Oncol; 2009 Nov; 100(6):481-3. PubMed ID: 19653258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Trans Am Ophthalmol Soc; 2008; 106():128-35; discussion 135-7. PubMed ID: 19277228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.